ORIGINAL ARTICLESUse of nebulized inhaled corticosteroids among older adult patients: an assessment of outcomes
REFERENCES (43)
- et al.
The health economics of asthma and rhinitis, I: assessing the economic impact
J Allergy Clin Immunol
(2001) - et al.
A comprehensive study of the direct and indirect costs of adult asthma
J Allergy Clin Immunol
(2003) - et al.
Underdiagnosis of asthma in the elderly
Br J Dis Chest
(1987) - et al.
Underdiagnosis and undertreatment of asthma in the elderly
Chest
(1999) What does it mean when a patient says, “my asthma medication is not working?”
Chest
(2004)Inhalers and nebulizers: which to choose and why
Respir Med
(1996)Guidelines for the use of nebulizers in the home and at domiciliary sites: report of a consensus conference: National Association for Medical Direction of Respiratory Care(NAMDRC) Consensus Group
Chest
(1996)- et al.
Consultation for asthma: results of a generalist survey
Ann Allergy Asthma Immunol
(1999) - et al.
Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study
Chest
(2003) - et al.
Patterns of inhaled asthma medication use: a 3-year longitudinal analysis of prescription claims data from British Columbia, Canada
Chest
(2002)
Asthma variability in patients previously treated with beta2-agonists alone
J Allergy Clin Immunol
Asthma prevalence and control characteristics by race/ethnicity—United States, 2002
MMWR Morb Mortal Wkly
High prevalence of current asthma and active smoking effect among the elderly
Clin Exp Allergy
Multiple logistic regression analysis of risk factors for the development of steroid-dependent asthma in the elderly: a comparison with younger asthmatics
Respiration
National Heart, Lung, and Blood Institute
Asthma Prevalence by Age, Gender, Race/Ethnicity, and Geographic Region/Division, 1999–2003
Increasing U.S. asthma mortality rates: who is really dying?
J Asthma
Comparing the national economic burden of five chronic conditions
Health Aff (Millwood)
Quality of life and economic features in elderly asthmatics
Respiration
Asthma Mortality by Age, Gender, Race/Ethnicity and Region/State, 1998–2002
Prevalence of untreated asthma in a population sample of 6000 older adults in Bristol, UK
Thorax
Cited by (13)
Nebulized Therapy. SEPAR Year
2014, Archivos de BronconeumologiaCitation Excerpt :Nebulized corticosteroids,19–28 principally budesonide20–23 (although also flunisolide,24 fluticasone,25 and beclomethasone26,27), can be considered an effective alternative in patients with asthma or COPD who are unwilling or unable to use other inhalation devices (Table 2). In a study of elderly patients with asthma or COPD who found it difficult to use other devices, Marcus et al.28 observed less use of systemic corticosteroids and fewer visits to the emergency department when long term treatment was maintained with nebulized corticosteroids. Maltais et al.22 compared the efficacy of nebulized budesonide and systemic corticosteroids in patients with COPD exacerbations and found no differences in FEV1 improvement, hospital stay, or adverse effects.
The Saudi initiative for asthma – 2024 update: Guidelines for the diagnosis and management of asthma in adults and children
2024, Annals of Thoracic MedicineDecalogue of nebulisation
2019, Pediatria i Medycyna RodzinnaUse of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study
2018, Therapeutic Advances in Respiratory DiseaseQuestionnaire survey for bronchial asthma in elderly care facilities
2018, Kobe Journal of Medical SciencesFlunisolide for the treatment of asthma
2014, Expert Review of Clinical Pharmacology
This study was supported by AstraZeneca, LP, Wilmington, DE. The following disclosures apply to the authors: Philip Marcus serves as a speaker and consultant for AstraZeneca and GlaxoSmithKline and receives unrestricted research support from these sources. Philip Marcus and Edward Oppenheimer received unrestricted honoraria from AstraZeneca for their involvement in this study. Laura Katz and John Doyle are employed by Analytica International, which received funding from AstraZeneca to conduct this study. At the time of this work, Pankaj Patel was a full-time employee of AstraZeneca.